News & Updates

Mississippi State University students turn toolbox into UV mask sterilizer for campus health center

Posted on

Mississippi State University mechanical engineering students have turned a conventional truck toolbox into a device that will sterilize face masks for the university’s John C. Longest Student Health Center staff. A team of two students, under the leadership of researchers at MSU’s Center for Advanced Vehicular Systems, built and tested the device before delivering it to the health center on Monday [April 13]. Built using low-cost materials, the device can sterilize 15-20 masks in minutes, filling a need for the health center during the COVID-19 pandemic and a nationwide shortage of masks.

Read more

Omaha medical researcher says he's excited about results of COVID-19 drug trial

Posted on

In a major international study that enrolled its first patient at the Nebraska Medical Center, the experimental drug, called remdesivir, shortened the time it takes for patients to recover by four days on average, U.S. government and company officials announced Wednesday. Gilead Sciences’ drug is the first treatment to pass such a stringent test against the virus, which has killed more than 218,000 people since it emerged late last year in China. The drug also showed a trend toward fewer deaths in patients who were ill enough to have lung involvement.

Read more

West Virginia Scientists produce solution needed for COVID-19 testing

Posted on

A team of scientists, pathologists and lab technicians from Marshall University and Mountain Health Network are helping West Virginia address a limited supply of the solution used to transport testing swabs for the novel coronavirus (COVID-19) by making the mixture in one of the university’s labs. The clear viral transport medium (VTM), composed of specialized reagents, keeps a virus viable on the nasopharyngeal swab for transport until testing is performed.

Read more

Marshall University’s Robert C. Byrd Institute ramps up production of protective equipment

Posted on

The Robert C. Byrd Institute (RCBI) at Marshall University is working around the clock to produce personal protective equipment as part of the fight to reduce the spread of the corona virus. Technicians in Charleston and Huntington are manufacturing N95 masks and face shields using RCBI’s stable of 3D printers and laser cutting technology, including one of the largest 3D printers in the state. The devices are being shipped to the West Virginia Army National Guard in Charleston where the face shields are assembled, and filters are added to the N95 masks before they are distributed around the state to health care workers and first responders.

Read more

WVU Rockefeller Neuroscience Institute and Oura Health unveil study to predict the outbreak of COVID-19 in healthcare professionals

Posted on

The West Virginia University Rockefeller Neuroscience Institute, WVU Medicine, and smart ring maker Oura Health announced (April 8) a national study designed to accelerate early detection of the COVID-19 virus symptoms and contagiousness. Leveraging an artificial intelligence -driven predictive model, wearable ring technology, and a COVID-19 monitoring app, RNI scientists and partners are developing an innovative “digital PPE” approach that potentially can identify infected frontline healthcare professionals before they become symptomatic – a possible breakthrough in monitoring capabilities and limiting the spread.

Read more

WVU Medicine receives FDA Investigational Drug Approval for COVID-19 immunotherapy

Posted on

WVU Medicine pediatric and adult allergist and immunologist Brian Peppers, D.O., Ph.D., has received Investigational New Drug approval from the U.S. Food and Drug Administration for the experimental treatment of COVID-19 using convalescent donor plasma. This is the first FDA approved Investigational New Drug trial for COVID-19 immunotherapy to include pediatric patients.

Read more

NIH clinical trial shows Remdesivir accelerates recovery from advanced COVID-19

Posted on

“Hospitalized patients with advanced COVID-19 and lung involvement who received remdesivir recovered faster than similar patients who received a placebo, according to a preliminary data analysis from a randomized, controlled trial involving 1063 patients, which began on February 21. The trial (known as the Adaptive COVID-19 Treatment Trial, or ACTT), sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is the first clinical trial launched in the United States to evaluate an experimental treatment for COVID-19.

Read more

UNH mobilizes campus 3D printers for medical face shield production

Posted on

Several faculty and staff used 15 of the university’s 3D printers to make much-needed protective equipment for medical personnel. The printers — many of them now humming in home garages and basements — are manufacturing the headbands that support face shields used by medical professionals on the front line of addressing the coronavirus. At a production rate of up to 50 per day, by April 2 the effort produced more than 300 headbands.

Read more

UNH community supports frontlines during COVID-19 crisis

Posted on

When COVID-19 began to spread, UNH Police Chief Paul Dean, who is also serving as vice president of public safety and risk management for the campus, put out the call for supplies across the university, and between his stockpile and contributions from labs and departments campus wide, has collected some 45,000 pairs of gloves, 11,000 surgical masks, 4,800 N-95 respirators, 216 protective gowns and 38 Tyvek suits. These are being distributed to hospitals and health care facilities in the region as they are needed and are also available to first responders in Newmarket and Dover and to caregivers at Durham’s new RiverWoods retirement community.

Read more

UNH New Research and Outreach Activities Related to Pandemic

Posted on

Since mid-March, the Carsey School of Public Policy at UNH has been responding to the COVID-19 pandemic by moving classes online, conducting and publishing research on new and emerging trends related to coronavirus, helping in the policy response, and by assisting communities to safely continue civic life during this period of individual isolation, while also preparing for re-engagement when limitations are lifted.

Read more
ex arrow-right check news twitter facebook Papers